3D images of cancer cells in the body: Medical physicists from Halle present new method

A picture of a tumor (green) generated with the newly developed technique. Jan Laufer

Clinicians and scientists are in need of a better understanding of cancer cells and their properties in order to provide targeted cancer treatment. Individual cancer cells are often examined in test tubes before the findings are tested in living organisms. “

Our aim is to visualise cancer cells inside the living body to find out how they function, how they spread and how they react to new therapies,” says medical physicist Professor Jan Laufer from MLU. He specialises in the field of photoacoustic imaging, a process that uses ultrasound waves generated by laser beams to produce high-resolution, three-dimensional images of the body’s interior.

“The problem is that tumour cells are transparent. This makes it difficult to use optical methods to examine tumours in the body,” explains Laufer whose research group has developed a new method to solve this problem: First the scientists introduce a specific gene into the genome of the cancer cells.

“Once inside the cells, the gene produces a phytochrome protein, which originates from plants and bacteria. There it serves as a light sensor,” Laufer continues. In the next step, the researchers illuminate the tissue with short pulses of light at two different wavelengths using a laser. Inside the body, the light pulses are absorbed and converted into ultrasonic waves.

These waves can then be measured outside the organism and two images of the body's interior can be reconstructed based on this data. “The special feature of phytochrome proteins is that they alter their structure and thus also their absorption properties depending on the wavelength of the laser beams.

This results in changes to the amplitude of the ultrasound waves that are generated in the tumour cells. None of the other tissue components, for example blood vessels, have this property – their signal remains constant,” Laufer says. By calculating the difference between the two images, a high-resolution, three-dimensional image of the tumour cells is created, which is free of the otherwise overwhelming background contrast.

The development of Halle's medical physicists can be applied to a wide range of applications in the preclinical research and the life sciences. In addition to cancer research, the method can be used to observe cellular and genetic processes in living organisms.

About the study:
J. Märk et. al, Dual-wavelength 3D photoacoustic imaging of mammalian cells using a photoswitchable phytochrome reporter protein. Communication Physics 2018, 1, 3. DOI: 10.1038/s42005-017-0003-2

Media Contact

Tom Leonhardt idw - Informationsdienst Wissenschaft

More Information:

http://www.uni-halle.de

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

New yttrium-hydrogen compounds discovered

Researchers at the University of Bayreuth have made a significant scientific breakthrough by discovering new yttrium-hydrogen compounds having serious implications for the research on high-pressure superconductivity. High-pressure superconductivity refers to…

New AI model detects ninety percent of lymphatic cancer cases

Medical image analysis using AI has developed rapidly in recent years. Now, one of the largest studies to date has been carried out using AI-assisted image analysis of lymphoma, cancer…

UTA preps giant particle detectors for neutrino project

Excavation of caverns part of Fermilab’s Deep Underground Neutrino Experiment. With excavation work complete at the site where four gigantic particle detectors for the international Deep Underground Neutrino Experiment (DUNE) will be…

Partners & Sponsors